Revenue Breakdown
Composition ()
No data
Revenue Streams
Zimmer Biomet Holdings Inc (ZBH) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Knees, accounting for 39.6% of total sales, equivalent to $792.40M. Other significant revenue streams include S E T and Hips. Understanding this composition is critical for investors evaluating how ZBH navigates market cycles within the Medical Equipment, Supplies & Distribution industry.
Profitability & Margins
Evaluating the bottom line, Zimmer Biomet Holdings Inc maintains a gross margin of 56.77%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 13.15%, while the net margin is 6.15%. These profitability ratios, combined with a Return on Equity (ROE) of 5.60%, provide a clear picture of how effectively ZBH converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, ZBH competes directly with industry leaders such as EXAS and WST. With a market capitalization of $19.47B, it holds a significant position in the sector. When comparing efficiency, ZBH's gross margin of 56.77% stands against EXAS's 70.11% and WST's 37.75%. Such benchmarking helps identify whether Zimmer Biomet Holdings Inc is trading at a premium or discount relative to its financial performance.
